These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 20980207)

  • 1. The European cystic fibrosis patient registry: the power of sharing data.
    Sheppard DN
    J Cyst Fibros; 2010 Dec; 9 Suppl 2():S1-2. PubMed ID: 20980207
    [No Abstract]   [Full Text] [Related]  

  • 2. The implementation of standards of care in Europe: state of the art.
    Colombo C; Littlewood J
    J Cyst Fibros; 2011 Jun; 10 Suppl 2():S7-15. PubMed ID: 21658645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Swiss registry for patients with cystic fibrosis: design, programming, implementation and first examples of use].
    Schöni-Affolter F; Oswald P; Wandt-Baumann C; Kriemler S; Schöni MH
    Schweiz Med Wochenschr; 2000 Sep; 130(39):1373-81. PubMed ID: 11059028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Commentary.
    Fahy N
    J Cyst Fibros; 2010 Dec; 9 Suppl 2():S3-4. PubMed ID: 21036676
    [No Abstract]   [Full Text] [Related]  

  • 5. Using disease registries for pharmacoepidemiological research: a case study of data from a cystic fibrosis registry.
    Strobl J; Enzer I; Bagust A; Haycox A; Smyth R; Ashby D; Walley T
    Pharmacoepidemiol Drug Saf; 2003 Sep; 12(6):467-73. PubMed ID: 14513660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guideline on the design and conduct of cystic fibrosis clinical trials: the European Cystic Fibrosis Society-Clinical Trials Network (ECFS-CTN).
    De Boeck K; Bulteel V; Tiddens H; Wagner T; Fajac I; Conway S; Dufour F; Smyth AR; Lee T; Sermet I; Kassai B; Elborn S;
    J Cyst Fibros; 2011 Jun; 10 Suppl 2():S67-74. PubMed ID: 21658644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient registry analyses: seize the data, but caveat lector.
    Schechter MS
    J Pediatr; 2008 Dec; 153(6):733-5. PubMed ID: 19014811
    [No Abstract]   [Full Text] [Related]  

  • 8. [The presentation of the project for realizing a national registry for cystic fibrosis].
    Barletta L; Bossi A; Bettinelli ME; Giunta A
    Epidemiol Prev; 1991; 13(48-49):192-3. PubMed ID: 1843313
    [No Abstract]   [Full Text] [Related]  

  • 9. Dornase alfa in the treatment of cystic fibrosis in Europe: a report from the Epidemiologic Registry of Cystic Fibrosis.
    Hodson ME; McKenzie S; Harms HK; Koch C; Mastella G; Navarro J; Strandvik B;
    Pediatr Pulmonol; 2003 Nov; 36(5):427-32. PubMed ID: 14520726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cystic fibrosis patient registries: A valuable source for clinical research.
    Dasenbrook EC; Sawicki GS
    J Cyst Fibros; 2018 Jul; 17(4):433-440. PubMed ID: 29555479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An overview of international literature from cystic fibrosis registries: 1. Mortality and survival studies in cystic fibrosis.
    Buzzetti R; Salvatore D; Baldo E; Forneris MP; Lucidi V; Manunza D; Marinelli I; Messore B; Neri AS; Raia V; Furnari ML; Mastella G
    J Cyst Fibros; 2009 Jul; 8(4):229-37. PubMed ID: 19419909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The European Cystic Fibrosis Society Patient Registry: valuable lessons learned on how to sustain a disease registry.
    Viviani L; Zolin A; Mehta A; Olesen HV
    Orphanet J Rare Dis; 2014 Jun; 9():81. PubMed ID: 24908055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A cystic fibrosis center in a general hospital: the Versailles experience].
    Foucaud P; Bonnel A; Ajzenman C; Le Monnier A; Le Jalle S; Borel B
    Arch Pediatr; 2010 Jun; 17(6):727-8. PubMed ID: 20654862
    [No Abstract]   [Full Text] [Related]  

  • 14. [Mucoviscidosis: comparative analysis of epidemiological data of French and North American registries].
    Rault G; Guilloud-Bataille M; Feingold J
    Rev Pneumol Clin; 1995; 51(3):115-21. PubMed ID: 7569572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EuroCareCF: working together to improve patient care and therapy development.
    Sheppard DN
    J Cyst Fibros; 2011 Jun; 10 Suppl 2():S1-4. PubMed ID: 21658628
    [No Abstract]   [Full Text] [Related]  

  • 16. An abnormal distribution of delta F508 genotypes in cystic fibrosis patient registries.
    Feingold J; Guilloud-Bataille M; De Crozes D
    Ann Genet; 1998; 41(1):31-3. PubMed ID: 9599649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of CF: How registries can be used to advance our understanding of the CF population.
    Jackson AD; Goss CH
    J Cyst Fibros; 2018 May; 17(3):297-305. PubMed ID: 29275954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Cystic Fibrosis Foundation Patient Registry as a tool for use in quality improvement.
    Schechter MS; Fink AK; Homa K; Goss CH
    BMJ Qual Saf; 2014 Apr; 23 Suppl 1():i9-14. PubMed ID: 24443584
    [No Abstract]   [Full Text] [Related]  

  • 19. EuroCareCF: a mighty effort and a huge success.
    Elborn JS
    J Cyst Fibros; 2011 Jun; 10 Suppl 2():S5-6. PubMed ID: 21658642
    [No Abstract]   [Full Text] [Related]  

  • 20. Improving the quality of care for patients with cystic fibrosis.
    Schechter MS; Gutierrez HH
    Curr Opin Pediatr; 2010 Jun; 22(3):296-301. PubMed ID: 20414114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.